Iron Triangle Partners LP's Q3 2022 13F: 9 new positions, 6 exits
Form 13F-HR for the quarter ended Sep 30, 2022 · filed Nov 14, 2022 · 27 reported positions · accession 0001172661-22-002382
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | ABBVIE INC (ABBV) | 8.6% | — | −8.6 pts | −350K sh | −100% |
| New | CHARLES RIV LABS INTL INC (CRL) | — | 6.9% | +6.9 pts | +202K sh | new |
| New | SANOFI (SNY) | — | 6.0% | +6.0 pts | +900K sh | new |
| Reduced | HUMANA INC (HUM) | 7.5% | 3.0% | −4.6 pts | −65,000 sh | −65% |
| Reduced | DEXCOM INC (DXCM) | 6.0% | 2.1% | −3.9 pts | −350K sh | −70% |
| Reduced | REPLIGEN CORP (RGEN) | 6.5% | 3.3% | −3.3 pts | −150K sh | −60% |
| Reduced | GUARDANT HEALTH INC (GH) | 6.4% | 4.6% | −1.9 pts | −503K sh | −51% |
| Exited | ASTRAZENECA PLC (AZN) | 4.7% | — | −4.7 pts | −437K sh | −100% |
| New | HCA HEALTHCARE INC (HCA) | — | 4.5% | +4.5 pts | +140K sh | new |
| Exited | LEGEND BIOTECH CORP (LEGN) | 4.4% | — | −4.4 pts | −495K sh | −100% |
| Exited | CONMED CORP (CNMD) | 4.0% | — | −4.0 pts | −260K sh | −100% |
| New | INARI MED INC (NARI) | — | 3.8% | +3.8 pts | +300K sh | new |
| New | INSULET CORP (PODD) | — | 3.2% | +3.2 pts | +80,000 sh | new |
| New | CATALENT INC (CTLT) | — | 3.2% | +3.2 pts | +250K sh | new |
| Increased | CIGNA CORP NEW (CI) | 3.4% | 6.9% | +3.5 pts | +63,010 sh | +79% |
| New | PACIFIC BIOSCIENCES CALIF IN (PACB) | — | 3.0% | +3.0 pts | +3M sh | new |
| New | SAREPTA THERAPEUTICS INC (SRPT) | — | 2.9% | +2.9 pts | +150K sh | new |
| New | ALNYLAM PHARMACEUTICALS INC (ALNY) | — | 2.8% | +2.8 pts | +80,000 sh | new |
| Reduced | ACADIA HEALTHCARE COMPANY IN (ACHC) | 6.0% | 4.8% | −1.2 pts | −200K sh | −36% |
| Reduced | ICON PLC (ICLR) | 5.6% | 2.7% | −2.9 pts | −76,202 sh | −48% |
| Reduced | BOSTON SCIENTIFIC CORP (BSX) | 6.0% | 4.7% | −1.3 pts | −300K sh | −30% |
| Increased | HORIZON THERAPEUTICS PUB L (HZNP) | 1.9% | 2.9% | +0.9 pts | +115K sh | +77% |
| Increased | SURGERY PARTNERS INC (SGRY) | 1.3% | 2.2% | +1.0 pts | +282K sh | +105% |
| Exited | KARYOPHARM THERAPEUTICS INC (KPTI) | 0.8% | — | −0.8 pts | −1.1M sh | −100% |
| Exited | SOMALOGIC INC (SLGC) | 0.7% | — | −0.7 pts | −1M sh | −100% |
| Reduced | BIO RAD LABS INC (BIO) | 4.6% | 3.6% | −1.0 pts | −7,955 sh | −14% |
| Reduced | HEALTHEQUITY INC (HQY) | 4.8% | 5.2% | +0.4 pts | −45,541 sh | −9% |
| Reduced | INSPIRE MED SYS INC (INSP) | 3.4% | 3.1% | −0.3 pts | −13,938 sh | −12% |
| Increased | 908 DEVICES INC (MASS) | 2.8% | 2.6% | −0.2 pts | +50,000 sh | +6% |
| Increased | NEUROCRINE BIOSCIENCES INC (NBIX) | 5.5% | 6.6% | +1.1 pts | +5,601 sh | +2% |
| Reduced | ESTABLISHMENT LABS HLDGS INC (ESTA) | 2.8% | 3.1% | +0.2 pts | −2,730 sh | −1% |
| Reduced | STEREOTAXIS INC (STXS) | 0.5% | 0.5% | 0.0 pts | −10,089 sh | −1% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 54.1% of the equity book
Changes in the top 10 this quarter: CRL entered · CI entered · SNY entered · HCA entered · NARI entered · ABBV left · HUM left · RGEN left · DXCM left · ICLR left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | CHARLES RIV LABS INTL INC (CRL) | 0.0% | 6.9% | Entered the top 10 |
| 2 | CIGNA CORP NEW (CI) | 3.4% | 6.9% | Entered the top 10 |
| 3 | NEUROCRINE BIOSCIENCES INC (NBIX) | 5.5% | 6.6% | |
| 4 | SANOFI (SNY) | 0.0% | 6.0% | Entered the top 10 |
| 5 | HEALTHEQUITY INC (HQY) | 4.8% | 5.2% | |
| 6 | ACADIA HEALTHCARE COMPANY IN (ACHC) | 6.0% | 4.8% | |
| 7 | BOSTON SCIENTIFIC CORP (BSX) | 6.0% | 4.7% | |
| 8 | GUARDANT HEALTH INC (GH) | 6.4% | 4.6% | |
| 9 | HCA HEALTHCARE INC (HCA) | 0.0% | 4.5% | Entered the top 10 |
| 10 | INARI MED INC (NARI) | 0.0% | 3.8% | Entered the top 10 |
| — | ABBVIE INC (ABBV) | 8.6% | 0.0% | Left the top 10 |
| — | HUMANA INC (HUM) | 7.5% | 3.0% | Left the top 10 |
| — | REPLIGEN CORP (RGEN) | 6.5% | 3.3% | Left the top 10 |
| — | DEXCOM INC (DXCM) | 6.0% | 2.1% | Left the top 10 |
| — | ICON PLC (ICLR) | 5.6% | 2.7% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| Exited | SPDR S&P 500 ETF TR (SPY) | Put | 400K | 0 | $0 |